# A Study of MG7 Redirected Autologous T Cells for Advanced MG7 Positive Liver Metastases(MG7-CART)

> **NCT02862704** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Xijing Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Liver Metastases

## Interventions

- **BIOLOGICAL:** MG7-CART

## Key facts

- **NCT ID:** NCT02862704
- **Lead sponsor:** Xijing Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-06
- **Primary completion:** 2017-05
- **Final completion:** 2017-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2016-08-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02862704

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02862704, "A Study of MG7 Redirected Autologous T Cells for Advanced MG7 Positive Liver Metastases(MG7-CART)". Retrieved via MORVS 2026-10-12 from https://api.morvs.ai/clinical/NCT02862704. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*